Guerbet (0ELV)

London
Currency in EUR
27.60
0.00(0.00%)
Real-time Data
0ELV Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
Fair Value
Day's Range
27.6027.60
52 wk Range
19.4239.70
Key Statistics
Edit
Prev. Close
16.42
Open
27.6
Day's Range
27.6-27.6
52 wk Range
19.42-39.7
Volume
-
Average Volume (3m)
319
1-Year Change
47.12%
Book Value / Share
30.9
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0ELV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 33 consecutive years
Show more

Guerbet Company Profile

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. Guerbet SA was incorporated in 1926 and is headquartered in Villepinte, France.

Compare 0ELV to Peers and Sector

Metrics to compare
0ELV
Peers
Sector
Relationship
P/E Ratio
10.4x33.8x−0.6x
PEG Ratio
0.061.790.00
Price/Book
0.9x3.2x2.6x
Price / LTM Sales
0.4x3.6x3.1x
Upside (Analyst Target)
-10.1%51.5%
Fair Value Upside
Unlock7.1%7.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.6
Dividend Yield
1.81%
Industry Median 1.52%
Annualised payout
0.5000
Paid annually
5-Years Growth
-10.07%
Growth Streak

Earnings

Latest Release
Oct 24, 2024
EPS / Forecast
-- / --
Revenue / Forecast
201.30M / 205.20M
EPS Revisions
Last 90 days

FAQ

What Is the Guerbet (0ELV) Stock Price Today?

The Guerbet stock price today is 27.60.

What Stock Exchange Does Guerbet Trade On?

Guerbet is listed and trades on the London stock exchange.

What Is the Stock Symbol for Guerbet?

The stock symbol for Guerbet is "0ELV."

Does Guerbet Pay Dividends? What’s The Current Dividend Yield?

The Guerbet dividend yield is 1.81%.

What Is the Guerbet Market Cap?

As of today, Guerbet market cap is 340.44M.

What is Guerbet Earnings Per Share?

The Guerbet EPS is 2.60.

What Is the Next Guerbet Earnings Date?

Guerbet will release its next earnings report on 24 Mar 2025.

From a Technical Analysis Perspective, Is 0ELV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.